MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D5E76D.9D8EF160"

Данный документ является веб-страницей в одном файле, также называемой файлом веб-архива. Если вы видите это сообщение, значит, данный браузер или редактор не поддерживает файлы веб-архива. Загрузите браузер, поддерживающий веб-архивы, например Windows® Internet Explorer®.

------=_NextPart_01D5E76D.9D8EF160
Content-Location: file:///C:/680B1694/UA104760101_4D34.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link rel=3DFile-List href=3D"UA104760101_4D34.files/filelist.xml">
<link rel=3DPreview href=3D"UA104760101_4D34.files/preview.wmf">
<title>ЗАТВЕРДЖЕНО</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>smnlka</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Bravada</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2015-01-06T07:52:00Z</o:LastPrinted>
  <o:Created>2020-02-19T19:43:00Z</o:Created>
  <o:LastSaved>2020-02-19T19:43:00Z</o:LastSaved>
  <o:Pages>3</o:Pages>
  <o:Words>965</o:Words>
  <o:Characters>5506</o:Characters>
  <o:Company>pharma-center</o:Company>
  <o:Lines>45</o:Lines>
  <o:Paragraphs>12</o:Paragraphs>
  <o:CharactersWithSpaces>6459</o:CharactersWithSpaces>
  <o:Version>14.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DthemeData href=3D"UA104760101_4D34.files/themedata.thmx">
<link rel=3DcolorSchemeMapping
href=3D"UA104760101_4D34.files/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:PunctuationKerning/>
  <w:DrawingGridHorizontalSpacing>6 пт</w:DrawingGridHorizontalSpacing>
  <w:DisplayHorizontalDrawingGridEvery>2</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>RU</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:DontUseIndentAsNumberingTabStop/>
   <w:FELineBreak11/>
   <w:WW11IndentRules/>
   <w:DontAutofitConstrainedTables/>
   <w:AutofitLikeWW11/>
   <w:HangulWidthLikeWW11/>
   <w:UseNormalStyleForList/>
   <w:DontVertAlignCellWithSp/>
   <w:DontBreakConstrainedForcedTables/>
   <w:DontVertAlignInTxbx/>
   <w:Word11KerningPairs/>
   <w:CachedColBalance/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"true"
  DefSemiHidden=3D"true" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"267">
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"35" QFormat=3D"true" Name=3D=
"caption"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" Name=3D"Default Paragraph=
 Font"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"20" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"59" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Placeho=
lder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" UnhideWhenUsed=3D"false" Name=3D"Revisio=
n"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" SemiHidden=3D"false"
   UnhideWhenUsed=3D"false" QFormat=3D"true" Name=3D"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" QFormat=3D"true" Name=3D=
"TOC Heading"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:204;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Обычный;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-font-kerning:0pt;
	mso-ansi-language:UK;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Верхний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 233.85pt right 467.75pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Нижний колонтитул Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 233.85pt right 467.75pt;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	font-style:italic;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0cm;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:UK;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Текст выноски Знак";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
p.Iauiue, li.Iauiue, div.Iauiue
	{mso-style-name:Iau?iue;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0cm;
	margin-bottom:.0001pt;
	mso-pagination:none;
	text-autospace:none;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
span.a
	{mso-style-name:"Текст выноски Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Текст выноски";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma","sans-serif";
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.knZulassung02, li.knZulassung02, div.knZulassung02
	{mso-style-name:knZulassung02;
	mso-style-unhide:no;
	margin-top:0cm;
	margin-right:14.2pt;
	margin-bottom:0cm;
	margin-left:92.15pt;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	text-autospace:none;
	font-size:12.0pt;
	font-family:Courier;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:DE;
	mso-fareast-language:DE;}
span.a0
	{mso-style-name:"Верхний колонтитул Знак";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Верхний колонтитул";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	mso-ansi-language:RU;
	mso-fareast-language:RU;}
span.a1
	{mso-style-name:"Нижний колонтитул Знак";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Нижний колонтитул";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	mso-ansi-language:RU;
	mso-fareast-language:RU;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("UA104760101_4D34.files/header.htm") fs;
	mso-footnote-continuation-separator:url("UA104760101_4D34.files/header.htm=
") fcs;
	mso-endnote-separator:url("UA104760101_4D34.files/header.htm") es;
	mso-endnote-continuation-separator:url("UA104760101_4D34.files/header.htm"=
) ecs;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:2.0cm 42.5pt 2.0cm 3.0cm;
	mso-header-margin:35.45pt;
	mso-footer-margin:35.45pt;
	mso-footer:url("UA104760101_4D34.files/header.htm") f1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 @list l0
	{mso-list-id:672757076;
	mso-list-type:hybrid;
	mso-list-template-ids:1808300020 554440366 68747267 68747269 68747265 6874=
7267 68747269 68747265 68747267 68747269;}
@list l0:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:36.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
@list l0:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:72.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:108.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:144.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:180.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:216.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l0:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:252.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l0:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:288.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l0:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:324.0pt;
	mso-level-number-position:left;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1
	{mso-list-id:819615501;
	mso-list-type:hybrid;
	mso-list-template-ids:-1622670550 554440366 68747267 68747269 68747265 687=
47267 68747269 68747265 68747267 68747269;}
@list l1:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:18.0pt;
	mso-level-number-position:left;
	margin-left:18.0pt;
	text-indent:-18.0pt;
	font-family:"Times New Roman","serif";
	mso-fareast-font-family:"Times New Roman";}
@list l1:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:54.0pt;
	mso-level-number-position:left;
	margin-left:54.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:90.0pt;
	mso-level-number-position:left;
	margin-left:90.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:126.0pt;
	mso-level-number-position:left;
	margin-left:126.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:162.0pt;
	mso-level-number-position:left;
	margin-left:162.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:198.0pt;
	mso-level-number-position:left;
	margin-left:198.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
@list l1:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:234.0pt;
	mso-level-number-position:left;
	margin-left:234.0pt;
	text-indent:-18.0pt;
	font-family:Symbol;}
@list l1:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:270.0pt;
	mso-level-number-position:left;
	margin-left:270.0pt;
	text-indent:-18.0pt;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l1:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:306.0pt;
	mso-level-number-position:left;
	margin-left:306.0pt;
	text-indent:-18.0pt;
	font-family:Wingdings;}
ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Обычная таблица";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
table.MsoTableGrid
	{mso-style-name:"Сетка таблицы";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0cm 5.4pt 0cm 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0cm;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman","serif";}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"1026"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DRU style=3D'tab-interval:35.4pt'>

<div class=3DWordSection1>

<p class=3DIauiue align=3Dright style=3D'text-align:right;mso-pagination:wi=
dow-orphan'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DIauiue align=3Dcenter style=3D'text-align:center;mso-pagination:=
widow-orphan'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-ansi-language:UK'>ІНСТРУКЦІЯ<o:p></o:p></span></b></p>

<p class=3DIauiue align=3Dcenter style=3D'text-align:center;mso-pagination:=
widow-orphan'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-ansi-language:UK'>для медичного застосування лікарського засобу<o:p></o=
:p></span></b></p>

<p class=3DIauiue align=3Dcenter style=3D'text-align:center;mso-pagination:=
widow-orphan'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DIauiue align=3Dcenter style=3D'text-align:center;mso-pagination:=
widow-orphan'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-ansi-language:UK'>ЕСПУМІЗАН<sup>®</sup> БЕБІ<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p>=
</span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Склад:</span></i>=
</b><i><span
lang=3DUK style=3D'mso-ansi-language:UK'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>діюча речовина: </span></i><span lang=3DUK
style=3D'mso-ansi-language:UK;mso-bidi-font-style:italic'>симетикон;<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>1 мл крапель оральних, емульсії, містить симетикону 100 мг;<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>допоміжні речовини:<=
/span></i><span
lang=3DUK style=3D'mso-ansi-language:UK'> макроголу стеарат, гліцерол монос=
теарат,
карбомери, ароматизатор із запахом банана, калію ацесульфам, сорбіт рідкий,=
 що
не кристалізується (Е 420), натрію хлорид, натрію цитрат, натрію гідроксид,=
 кислота
сорбінова<span style=3D'mso-no-proof:yes'>, вода очищена.</span><o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'>Лікарська форма.</span></b><span lang=3DUK
style=3D'mso-ansi-language:UK'> Краплі оральні, емульсія<span style=3D'mso-=
bidi-font-weight:
bold'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK;mso-bidi-font-weight:bold'>Основні фізико-хім=
ічні
властивості</span></i><span lang=3DUK style=3D'mso-ansi-language:UK;mso-bid=
i-font-weight:
bold;mso-bidi-font-style:italic'>: малов’язка емульсія молочно-білого кольо=
ру з
фруктовим банановим запахом.</span><i style=3D'mso-bidi-font-style:normal'>=
<span
lang=3DUK style=3D'mso-ansi-language:UK;mso-bidi-font-weight:bold'><o:p></o=
:p></span></i></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'><o:p>&nbsp;</o:p>=
</span></b></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Фармакотерапевтич=
на
група.</span></b><span lang=3DUK style=3D'font-size:12.0pt;mso-ansi-languag=
e:UK'> <span
style=3D'mso-bidi-font-weight:bold'>Засоби, що впливають на травний тракт та
метаболізм. Засоби, що застосовуються у разі функціональних розладів з боку
травного тракту</span></span><span style=3D'font-size:12.0pt;mso-bidi-font-=
weight:
bold'>.</span><span style=3D'font-size:12.0pt;mso-ansi-language:UK;mso-bidi=
-font-weight:
bold'> <span lang=3DUK>Інші засоби, що застосовуються у разі функціональних
розладів з боку травного тракту. Силікони.<o:p></o:p></span></span></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK;mso-bidi-font-weig=
ht:bold'>Код
АТ</span><span lang=3DEN-US style=3D'font-size:12.0pt;mso-ansi-language:EN-=
US;
mso-bidi-font-weight:bold'>X</span><span lang=3DUK style=3D'font-size:12.0p=
t;
mso-ansi-language:UK;mso-bidi-font-weight:bold'> А03A X13.<o:p></o:p></span=
></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'><o:p>&nbsp;</o:p>=
</span></i></b></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Фармакологічні
властивості.<o:p></o:p></span></i></b></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-ansi-language:UK'>Фармакодинаміка.<o:p></o:p></span></i></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Еспумізан<sup>®</=
sup> Бебі
містить діючу речовину симетикон, стабільний, поверхнево-активний полідимет=
илсилоксан.
Він змінює поверхневий натяг бульбашок газу, присутніх у харчових масах та =
слизі
травного тракту, і таким чином руйнує їх.<o:p></o:p></span></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Вивільнені при ць=
ому гази
можуть потім всмоктуватися стінкою кишечнику, а також видалятися при його
перистальтиці.<o:p></o:p></span></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Симетикон чинить =
фізичну
дію і не бере участі у хімічних або ферментативних реакціях.<o:p></o:p></sp=
an></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'font-size:12.=
0pt;
mso-ansi-language:UK'>Фармакокінетика.<o:p></o:p></span></i></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Симетикон не всмо=
ктується
після перорального застосування і виводиться у незміненому вигляді після
проходження через шлунково-кишковий тракт.<o:p></o:p></span></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DUK style=3D'font-size:12=
.0pt;
mso-ansi-language:UK'>Клінічні характеристики.<o:p></o:p></span></b></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Показання.</span>=
</i></b><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DEN-US style=3D'font-size:12.0pt;mso-ansi-language:EN-US'><o:p></o:p>=
</span></i></b></p>

<p class=3DIauiue style=3D'margin-left:18.0pt;text-align:justify;text-inden=
t:-18.0pt;
mso-pagination:widow-orphan;mso-list:l1 level1 lfo2;tab-stops:list 18.0pt'>=
<![if !supportLists]><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'><span style=3D'ms=
o-list:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'font-size:12.0pt;
mso-ansi-language:UK'>Симптоматичне лікування при скаргах з боку
шлунково-кишкового тракту, пов’язаних із газоутворенням, наприклад, метеори=
зм,
в тому числі в післяопераційний період; коліки у немовлят</span><span
style=3D'font-size:12.0pt'>.</span><span lang=3DUK style=3D'font-size:12.0p=
t;
mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DIauiue style=3D'margin-left:18.0pt;text-align:justify;text-inden=
t:-18.0pt;
mso-pagination:widow-orphan;mso-list:l1 level1 lfo2;tab-stops:list 18.0pt'>=
<![if !supportLists]><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'><span style=3D'ms=
o-list:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'font-size:12.0pt;
mso-ansi-language:UK'>Як допоміжний засіб при проведенні діагностичних
досліджень органів черевної порожнини (рентгенографія, ультразвукове
дослідження) та підготовка до гастродуоденоскопії.<o:p></o:p></span></p>

<p class=3DIauiue style=3D'margin-left:18.0pt;text-align:justify;text-inden=
t:-18.0pt;
mso-pagination:widow-orphan;mso-list:l1 level1 lfo2;tab-stops:list 18.0pt'>=
<![if !supportLists]><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'><span style=3D'ms=
o-list:
Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DUK style=3D'font-size:12.0pt;
mso-ansi-language:UK'>Як піногасник при інтоксикаціях поверхнево</span><span
style=3D'font-size:12.0pt'>-</span><span lang=3DUK style=3D'font-size:12.0p=
t;
mso-ansi-language:UK'>активними речовинами (пральні порошки або миючі засоб=
и).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:224.35pt'><b><o:=
p>&nbsp;</o:p></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:224.35pt'><b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-ansi-lang=
uage:UK'>Протипоказання.</span></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-ansi-lang=
uage:UK'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify;tab-stops:224.35pt'><span =
lang=3DUK
style=3D'mso-ansi-language:UK'>Підвищена чутливість до діючої речовини або =
до будь-якої
з допоміжних речовин, перелічених у розділі «Склад», повна кишкова
непрохідність.<o:p></o:p></span></p>

<p class=3DMsoBodyText3><b><i style=3D'mso-bidi-font-style:normal'><span la=
ng=3DUK><o:p>&nbsp;</o:p></span></i></b></p>

<p class=3DMsoBodyText3><b><i style=3D'mso-bidi-font-style:normal'><span la=
ng=3DUK>Взаємодія
з іншими лікарськими засобами та інші види взаємодій.</span></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK><o:p></o:p></span></i>=
</p>

<p class=3DMsoBodyText3><span lang=3DUK>На сьогодні невідомі.</span><span
style=3D'mso-ansi-language:RU'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p>=
</span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Особливості засто=
сування.<o:p></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-style:italic'>Препарат слід застосовувати з обережністю па=
цієнтам
з обструктивними захворюваннями шлунково-кишкового тракту.<o:p></o:p></span=
></p>

<p class=3DMsoBodyText3><span lang=3DUK>При появі нових скарг та/або скарг,=
 що
зберігаються після 14 днів лікування, необхідно провести клінічне обстеженн=
я.</span></p>

<p class=3DMsoBodyText3><span lang=3DUK>У зв’язку із загрозою проковтування=
 мірний
стаканчик слід зберігати у недоступному для дітей місці.</span></p>

<p class=3DMsoBodyText3><span lang=3DUK>Еспумізан<sup>®</sup> Бебі містить =
139 мг
сорбіту в 1 мл крапель, тому цей лікарський засіб не слід приймати хворим із
рідкісною спадковою формою непереносимості фруктози.</span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p>=
</span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Застосування у пе=
ріод
вагітності або годування груддю.</span></i></b><span lang=3DUK style=3D'mso=
-ansi-language:
UK;mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-weight:bold'>Клінічних даних щодо впливу лікарського засоб=
у </span><span
lang=3DUK style=3D'mso-ansi-language:UK'>Еспумізан<sup>®</sup> Бебі на вагі=
тність немає<span
style=3D'mso-bidi-font-weight:bold'>. Слід дотримуватись обережності у разі
призначення вагітним жінкам.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p>=
</span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Здатність впливат=
и на
швидкість реакції при керуванні автотранспортом або іншими механізмами.</sp=
an></i></b><span
lang=3DUK style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-weight:bold'>Особливих застережень немає.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><o:p>&nbsp;</o:p></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'ms=
o-ansi-language:
UK'>Спосіб застосування та дози.<o:p></o:p></span></i></b></p>

<p class=3DMsoBodyText3><span lang=3DUK>Перед застосуванням добре збовтати.=
 Для належного
дозування крапель флакон тримати вертикально наконечником-піпеткою донизу. =
До кришки
флакона-крапельниці по 30&nbsp;мл або по 50&nbsp;мл як дозувальний пристрій
прикріплений мірний стаканчик з нанесеною шкалою у мілілітрах. У разі
необхідності (наприклад, при застосуванні дози 25 крапель та вище), його мо=
жна
використовувати для відмірювання дози замість наконечника-піпетки. 25 крапе=
ль
дорівнює 1</span><span lang=3DEN-US style=3D'mso-ansi-language:EN-US'>&nbsp=
;</span><span
lang=3DUK>мл лікарського засобу (або 100&nbsp;мг симетикону).</span></p>

<p class=3DMsoBodyText2><u><span lang=3DUK style=3D'mso-bidi-font-size:12.0=
pt;
font-style:normal'>Для симптоматичного лікування розладів з боку травної си=
стеми,
спричинених газоутворенням.<o:p></o:p></span></u></p>

<p class=3DMsoBodyText2><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
font-style:normal'>Препарат застосовувати під час або після їди, а за необх=
ідності
– перед сном.<o:p></o:p></span></p>

<p class=3DMsoBodyText2><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
font-style:normal'>Тривалість лікування залежить від наявності скарг</span>=
<span
lang=3DUK style=3D'mso-bidi-font-size:12.0pt'>.</span><span lang=3DUK
style=3D'mso-bidi-font-size:12.0pt;font-style:normal'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Немовлята:</span></i=
><span
lang=3DUK style=3D'mso-ansi-language:UK;mso-bidi-font-style:italic'> 5–10 к=
рапель
на пляшку з дитячим харчуванням при кожному годуванні або 5–10 крапель перед
кожним годуванням груддю (дають дитині за допомогою чайної </span><span
lang=3DUK style=3D'mso-ansi-language:UK'>ложки).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Діти 1–6 років: </span></i><span lang=3DUK
style=3D'mso-ansi-language:UK'>по 10 крапель 3–5 разів на добу.<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Діти 6–14 років:</span></i><span lang=3DUK
style=3D'mso-ansi-language:UK'> по 10–20 крапель 3–5 разів на добу.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Діти від 14 років та дорослі:</span></i><span
lang=3DUK style=3D'mso-ansi-language:UK'> по 20 крапель 3–5 разів на добу.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><u><span lang=3DUK
style=3D'mso-ansi-language:UK;mso-bidi-font-style:italic'>Для підготовки до
рентгенологічного або ультразвукового дослідження.<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Дорослі:</span></i><=
span
lang=3DUK style=3D'mso-ansi-language:UK;mso-bidi-font-style:italic'> по 1&n=
bsp;мл
після їди 3 рази на добу перед проведенням дослідження та 1&nbsp;мл вранці в
день обстеження. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><u><span lang=3DUK
style=3D'mso-ansi-language:UK;mso-bidi-font-style:italic'>Як добавка до сус=
пензії
контрастної речовини.<o:p></o:p></span></u></p>

<p class=3DMsoBodyText2><span lang=3DUK style=3D'mso-bidi-font-size:12.0pt;
mso-bidi-font-style:italic'>Дорослі:</span><span lang=3DUK style=3D'mso-bid=
i-font-size:
12.0pt;font-style:normal'> 2–4 мл на 1 л суспензії для проведення подвійного
контрастування.<o:p></o:p></span></p>

<p class=3DMsoBodyText2><u><span lang=3DUK style=3D'mso-bidi-font-size:12.0=
pt;
font-style:normal'>Для підготовки до гастродуоденоскопії.<o:p></o:p></span>=
</u></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Дорослі:</span></i><span lang=3DUK style=3D'=
mso-ansi-language:
UK'> 2–3 мл перед проведенням дослідження. У разі необхідності під час
дослідження через інструментальний канал ендоскопа можна додатково ввести ще
декілька мілілітрів емульсії для усунення бульбашок піни, що заважають.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><u><span lang=3DUK
style=3D'mso-ansi-language:UK'>Як антидот при отруєнні поверхнево-активними
речовинами залежно від тяжкості отруєння.</span></u></p>

<p class=3DMsoNormal style=3D'text-align:justify'><i><span lang=3DUK
style=3D'mso-ansi-language:UK'>Дорослі:</span></i><span lang=3DUK style=3D'=
mso-ansi-language:
UK'> 4–8 мл одноразово. <i>Діти:</i> 1–4 мл одноразово.</span><u><o:p></o:p=
></u></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p>=
</span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><i><span lang=3DUK style=3D'mso-ansi-language:UK'>Діти.<o:p></o:p><=
/span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK;mso-bidi-font-weight:bold'>Препарат застосовують у педіатричній практиці=
.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i style=3D'mso-bidi-f=
ont-style:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Передозування.</span=
></i></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DUK style=3D'mso-ansi-lang=
uage:UK'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Дотепер випадки інтоксикацій після застосування симетикону невідомі.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Оскільки симетикон не всмоктується та не підлягає хімічному та фермента=
тивному
перетворенню під час проходження через шлунково-кишковий тракт, інтоксикація
практично виключена. Навіть значна кількість препарату Еспумізан<sup>®</sup=
> Бебі
переноситься без симптомів інтоксикації. У разі застосування доз більших, н=
іж
рекомендовано, слід звернутися до лікаря.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><i style=3D'mso-bidi-f=
ont-style:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Побічні реакції.<o:p=
></o:p></span></i></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>В окремих випадках при застосуванні препарату спостерігалися шкірні реа=
кції
гіперчутливості, включаючи свербіж, шкірне висипання, кропив’янку.<o:p></o:=
p></span></p>

<p class=3DknZulassung02 style=3D'margin-left:0cm;text-align:justify'><i><s=
pan
lang=3DUK style=3D'font-family:"Times New Roman","serif";letter-spacing:-.0=
5pt;
mso-ansi-language:UK;mso-fareast-language:RU'>Повідомлення про підозрювані
побічні реакції.<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
letter-spacing:
-.05pt;mso-ansi-language:UK;mso-bidi-font-style:italic'>Повідомлення про
підозрювані побічні реакції після реєстрації лікарського засобу відіграють
важливу роль. Це дає змогу продовжувати спостереження за співвідношенням
користі та ризику застосування лікарського засобу. Працівники галузі охорони
здоров’я повинні повідомляти про будь-які підозрювані побічні реакції.</spa=
n><span
lang=3DUK style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'>Термін придатності.</span></b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>3 роки.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Термін придатності після першого відкриття флакона – 6 місяців.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Не застосовувати препарат після закінчення терміну придатності, зазначе=
ного
на упаковці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'>Умови зберігання.</span></b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Спеціальні умови зберігання не вимагаються.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-ansi-language:UK'>Лікарсь=
кий засіб
зберігати у недоступному для дітей місці.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b><span lang=3DUK
style=3D'mso-ansi-language:UK'>Упаковка.</span></b><span lang=3DUK
style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'>По 30<span lang=3DUK
style=3D'mso-ansi-language:UK'>&nbsp;</span>мл або по 50<span lang=3DUK
style=3D'mso-ansi-language:UK'>&nbsp;</span>мл у флаконі з насадкою для доз=
ування
крапель, кришкою, що загвинчується, та мірн<span lang=3DUK style=3D'mso-ans=
i-language:
UK'>им</span><span lang=3DUK> </span><span lang=3DUK style=3D'mso-ansi-lang=
uage:UK'>стаканчиком</span>;
1 флакон у картонній коробці.<span lang=3DUK style=3D'mso-ansi-language:UK'=
><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'><o:p>&nbsp;</o:p></s=
pan></b></p>

<p class=3DMsoNormal style=3D'text-align:justify'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DUK style=3D'mso-ansi-language:UK'>Категорія відпуску.<=
/span></b><span
lang=3DUK style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'>Без рецепта.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify'><span lang=3DUK style=3D'=
mso-ansi-language:
UK'><o:p>&nbsp;</o:p></span></p>

<p class=3DIauiue style=3D'text-align:justify;mso-pagination:widow-orphan'>=
<b><span
lang=3DUK style=3D'font-size:12.0pt;mso-ansi-language:UK'>Виробник.<o:p></o=
:p></span></b></p>

<p class=3DMsoBodyText align=3Dleft style=3D'text-align:left'><span lang=3D=
UK
style=3D'font-style:normal;mso-bidi-font-style:italic'>БЕРЛІН-ХЕМІ АГ.<o:p>=
</o:p></span></p>

<p class=3DMsoBodyText align=3Dleft style=3D'text-align:left'><span lang=3D=
UK><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><b><span lang=3DUK style=3D'mso-ansi-language:UK'>Місц=
езнаходження
виробника та адреса місця провадження його діяльності.</span></b><span lang=
=3DUK
style=3D'mso-ansi-language:UK'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DUK style=3D'mso-ansi-language:UK'>Глініке=
р Вег 125,
12489 Берлін, Німеччина.<o:p></o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D5E76D.9D8EF160
Content-Location: file:///C:/680B1694/UA104760101_4D34.files/preview.wmf
Content-Transfer-Encoding: base64
Content-Type: image/x-wmf
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==

------=_NextPart_01D5E76D.9D8EF160
Content-Location: file:///C:/680B1694/UA104760101_4D34.files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D5E76D.9D8EF160
Content-Location: file:///C:/680B1694/UA104760101_4D34.files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D5E76D.9D8EF160
Content-Location: file:///C:/680B1694/UA104760101_4D34.files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1251"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
1">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 14">
<meta name=3DOriginator content=3D"Microsoft Word 14">
<link id=3DMain-File rel=3DMain-File href=3D"../UA104760101_4D34.htm">
<![if IE]>
<base href=3D"file:///C:\680B1694\UA104760101_4D34.files\header.htm"
id=3D"webarch_temp_base_tag">
<![endif]>
</head>

<body lang=3DRU>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-separato=
r'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-continua=
tion-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-separato=
r'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal><span style=3D'mso-special-character:footnote-continua=
tion-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dright style=3D'text-align:right'><!--[if suppo=
rtFields]><span
style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'> </span>PAGE<span style=3D'mso-spacerun:yes'>  
</span>\* MERGEFORMAT <span style=3D'mso-element:field-separator'></span><!=
[endif]--><span
style=3D'mso-no-proof:yes'>1</span><!--[if supportFields]><span style=3D'ms=
o-no-proof:
yes'><span style=3D'mso-element:field-end'></span></span><![endif]--><span
lang=3DUK style=3D'mso-ansi-language:UK'> з 3</span></p>

</div>

</body>

</html>

------=_NextPart_01D5E76D.9D8EF160
Content-Location: file:///C:/680B1694/UA104760101_4D34.files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../UA104760101_4D34.htm"/>
 <o:File HRef=3D"preview.wmf"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D5E76D.9D8EF160--
